GW Pharmaceuticals PLC Director/PDMR Shareholding (9873N)
November 01 2016 - 5:58AM
UK Regulatory
TIDMGWP
RNS Number : 9873N
GW Pharmaceuticals PLC
01 November 2016
Notification and public disclosure of transactions by persons
discharging
managerial responsibilities and persons closely associated with
them
1. Details of the person discharging managerial
responsibilities / person closely associated
--- -------------------------------------------------------------------------
a. Name Mr James Noble
--- ------------------------------ -----------------------------------------
2. Reason for the notification
--- -------------------------------------------------------------------------
a. Position/status non-executive Director/Deputy
Chairman
--- ------------------------------ -----------------------------------------
b. Initial Initial notification
notification
/Amendment
--- ------------------------------ -----------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -------------------------------------------------------------------------
a. Name GW Pharmaceuticals PLC
--- ------------------------------ -----------------------------------------
b. LEI
--- ------------------------------ -----------------------------------------
4. Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -------------------------------------------------------------------------
a. Description
of the Ordinary shares of 0.1p each ISIN:
Financial GB0030544687
instrument, Restricted American Depositary
type of Shares: ISIN: US36197T1372
instrument
Identification
code
--- ------------------------------ -----------------------------------------
b. Nature of Conversion of 27,492 Ordinary shares
the transaction into 2,291 Nasdaq listed Restricted
ADRs (12 to 1 Conversion ratio)
--- ------------------------------ -----------------------------------------
c. Price(s) Price(s) Volume(s)
and volume(s) - 2,291 ADSs issued upon
conversion of
27,492 Ordinary
shares
--------- ---------- ----------------
--- ------------------------------ -----------------------------------------
d. Aggregated
information
* Aggregated volume n/a
* Price
--- ------------------------------ -----------------------------------------
e. Date of 31 October 2016
the transaction
--- ------------------------------ -----------------------------------------
f. Place of New York
the transaction
--- ------------------------------ -----------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLIFEALELLIIR
(END) Dow Jones Newswires
November 01, 2016 05:58 ET (09:58 GMT)
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Nov 2024 to Dec 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Dec 2023 to Dec 2024